GoKawiilResearchers develop nanoparticles designed to cross the blood-brain barrier
Scientists are engineering particle-based delivery systems intended to ferry large molecules such as proteins and messenger RNA past the blood-brain barrier, a membrane that normally blocks such compounds from reaching brain tissue. Small chemicals like paracetamol already pass through naturally, but bigger therapeutic molecules cannot, limiting treatment options for brain disorders.
GoKawiil's interpretation of the reporting above, not reported fact.
The blood-brain barrier exists to protect the brain from toxins and pathogens, but that same protection prevents many promising drugs, including gene and RNA therapies, from reaching neurological tissue. A reliable way to breach it safely could open treatment paths for conditions like Alzheimer's, brain tumors, and other central nervous system diseases that currently have few effective options.
- The blood-brain barrier blocks large molecules like proteins and mRNA from reaching the brain.
- New particle-based delivery methods aim to safely transport bigger therapeutic molecules across this barrier.
- Success could unlock treatments for previously hard-to-treat brain diseases.
Source: nature.com — Makin, 2026-09-09
Published there as: “Drug-delivering particles aim to breach the blood–brain barrier”
Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.